PranitaDTammaMD

PubMed

• Assessing the impact of meropenem exposure on ceftolozane/tazobactam-resistance development in Pseudomonas aeruginosa using in vitro serial passage.
  Aliaa Fouad, Samantha E Nicolau, Patricia J Simner, David P Nicolau, Christian M Gill, Pranita D Tamma> ;The Journal of Antimicrobial Chemotherapy. 2024 Apr 2
• The metallo-β-lactamases strike back: emergence of taniborbactam escape variants.
  Munita, J., Tamma, P.> ;Antimicrobial Agents and Chemotherapy. 2024 Feb 7
• 1 citations
  Transition to Oral Antibiotic Therapy for Hospitalized Adults With Gram-Negative Bloodstream Infections.
  Drew W Engers, Pranita D Tamma, Suiyini Fiawoo, Karen Fong, Ripal Jariwala, Timothy C Jenkins, Ronald E Kendall, Jae Hyoung Lee, Erin K McCreary, Payal K Patel, Kather...> ;JAMA Network Open. 2024 Jan 2
• Understanding the role of antibiotic-associated adverse events in influencing antibiotic decision-making.
  Helsel, T., Jones, G., Virk, Z., Salinas, A., Grieb, S., Klein, E., , Cherian, J., Tamma, P., Cosgrove, S.> ;Antimicrobial Stewardship & Healthcare Epidemiology. 2024 Jan 1
• 1 citations
  Cefepime versus carbapenems for treatment of AmpC beta-lactamase-producing Enterobacterales bloodstream infections.
  Julia Herrmann, Anne-Valérie Burgener-Gasser, Daniel Goldenberger, Jan Roth, Maja Weisser, Pranita D Tamma, Sarah Tschudin-Sutter> ;European Journal of Clinical Microbiology & Infectious Diseases. 2024 Feb 1
• Is Carbapenem Therapy Necessary for the Treatment of Non-CTX-M ESBL-Producing Enterobacterales Bloodstream Infections?
  Dariusz A Hareza, Sara E Cosgrove, Patricia J Simner, Anthony D Harris, Yehudit Bergman, Rick Conzemius, Emily Jacobs, Stephan Beisken, Pranita D Tamma> ;Clinical Infectious Diseases. 2023 Nov 16
• 1 citations
  Interlaboratory comparison ofphage susceptibility testing.
  Krupa Parmar, Lauren Komarow, Damon W Ellison, Andrey A Filippov, Mikeljon P Nikolich, Joseph R Fackler, Martin Lee, Anjna Nair, Priyesh Agrawal, Pranita D Tamma, Mari...> ;Journal of Clinical Microbiology. 2023 Dec 19
• 1 citations
  Priorities and Progress in Gram-negative Bacterial Infection Research by the Antibacterial Resistance Leadership Group.
  Michael J Satlin, David van Duin, Pranita D Tamma, Thomas P Lodise, Daria Van Tyne, Keith A Rodvold, Nadine Rouphael, Scott R Evans, Vance G Fowler, Toshimitsu Hamasak...> ;Clinical Infectious Diseases. 2023 Oct 16
• Trimethoprim-Sulfamethoxazole for Pediatric Osteoarticular Infections.
  Suiyini Fiawoo, Pranita D Tamma, Rebecca G Same, Lauren M McDaniel> ;Journal of the Pediatric Infectious Diseases Society. 2023 Oct 28
• 1 citations
  Identifying Effective Durations of Antibiotic Therapy for the Treatment of Carbapenem-resistant Enterobacterales Bloodstream Infections: A Multicenter Observational St...
  Caitlin L Soto, Alice J Hsu, Jae Hyoung Lee, Kathryn Dzintars, Rebecca Choudhury, Timothy C Jenkins, Erin K McCreary, Katelyn S Quartuccio, Erica J Stohs, Matty Zimmer...> ;Clinical Infectious Diseases. 2024 Jan 25
• 5 citations
  Refractory Pseudomonas aeruginosa infections treated with phage PASA16: A compassionate use case series.
  Hadil Onallah, Ronen Hazan, Ran Nir-Paz, , Michael J Brownstein, Joseph R Fackler, Bri'Anna Horne, Robert Hopkins, Subhendu Basu, Ortal Yerushalmy, Sivan Alkalay-Oren,...> ;Med. 2023 Sep 8
• 88 citations
  Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections.
  Pranita D Tamma, Samuel L Aitken, Robert A Bonomo, Amy J Mathers, David van Duin, Cornelius J Clancy> ;Clinical Infectious Diseases. 2023 Jul 18
• 5 citations
  Infectious Diseases Consultation Associated With Reduced Mortality in Gram-Negative Bacteremia.
  Stephanie Shulder, Pranita D Tamma, Suiyini Fiawoo, Kathryn Dzintars, Daniel Escobar, Daniel J Livorsi, Anurag N Malani, Danica Palacio, Emily S Spivak, Matty Zimmerma...> ;Clinical Infectious Diseases. 2023 Nov 11
• 1 citations
  Epidemiology of Gram-Negative Bloodstream Infections in the United States: Results From a Cohort of 24 Hospitals.
  Dilek Ince, Suiyini Fiawoo, Rebecca Choudhury, David Dobrzynski, Howard Gold, Jae Hyoung Lee, Kelly M Percival, Stephanie Shulder, Deepthi Sony, Emily S Spivak, Pranit...> ;Open Forum Infectious Diseases. 2023 Jul 1
• 5 citations
  An NDM-ProducingClinical Isolate Exhibiting Resistance to Cefiderocol and the Combination of Ceftazidime-Avibactam and Aztreonam: Another Step Toward Pan-β-Lactam Resi...
  Patricia J Simner, Yehudit Bergman, Rick Conzemius, Emily Jacobs, Tsigereda Tekle, Stephan Beisken, Pranita D Tamma> ;Open Forum Infectious Diseases. 2023 Jul 1
• 2 citations
  Does the SCOUT Trial Fall Short of Determining an Effective Treatment Duration for Pediatric Urinary Tract Infections?
  Aaron M Milstone, Pranita D Tamma> ;JAMA Pediatrics. 2023 Aug 1
• An Electronic Algorithm to Identify Vancomycin-Associated Acute Kidney Injury.
  Jerald P Cherian, George F Jones, Preetham Bachina, Taylor Helsel, Zunaira Virk, Jae Hyoung Lee, Suiyini Fiawoo, Alejandra Salinas, Kate Dzintars, Elizabeth O'Shaughne...> ;Open Forum Infectious Diseases. 2023 Jun 1
• Multicentre genetic diversity study of carbapenem-resistant Enterobacterales: predominance of untypeable pUVA-likebearing plasmids.
  Patricia J Simner, Yehudit Bergman, Yunfan Fan, Emily B Jacobs, Srividya Ramakrishnan, Jennifer Lu, Shawna Lewis, Ann Hanlon, Pranita D Tamma, Michael C Schatz, Winsto...> ;JAC-Antimicrobial Resistance. 2023 Jun 1
• Launches a New Section Focused on Innovative Antimicrobial Stewardship Studies.
  Pranita D Tamma, Cesar A Arias, Ryan K Shields> ;Antimicrobial Agents and Chemotherapy. 2023 Jun 15
• 15 citations
  Navigating Available Treatment Options for Carbapenem-Resistant Acinetobacter baumannii-calcoaceticus Complex Infections.
  Ryan K Shields, David L Paterson, Pranita D Tamma> ;Clinical Infectious Diseases. 2023 May 1
• Reply to Bulloch.
  Jae Hyoung Lee, John McAteer, Pranita D Tamma> ;Clinical Infectious Diseases. 2023 Aug 14
• 1 citations
  Broad- Versus Narrow-Spectrum Perioperative Antibiotics and Outcomes in Pediatric Congenital Heart Disease Surgery: Analysis of the Vizient Clinical Data Base.
  Peter B Cooch, Mi-Ok Kim, Naveen Swami, Pranita D Tamma, Sarah Tabbutt, Martina A Steurer, Rachel L Wattier> ;Journal of the Pediatric Infectious Diseases Society. 2023 Apr 28
• The Frequency of Extended-Spectrum β-Lactamase Genes Harbored by Enterobacterales Isolates at High Risk for Clinically Significant ChromosomalExpression.
  Dariusz Hareza, Patricia J Simner, Yehudit Bergman, Emily Jacobs, Sara E Cosgrove, Pranita D Tamma> ;Open Forum Infectious Diseases. 2023 Apr 1
• 6 citations
  Successful Treatment of PersistentBacteremia With Cefiderocol in an Infant.
  Alice J Hsu, Patricia J Simner, Yehudit Bergman, Amy J Mathers, Pranita D Tamma> ;Open Forum Infectious Diseases. 2023 Apr 1
• Reply to Davis et al.
  Pranita D Tamma, Amy J Mathers, Eric Wenzler> ;Clinical Infectious Diseases. 2023 Jul 5
• Join now to see all

Journal Articles

• Association of a Safety Program for Improving Antibiotic Use with Antibiotic Use and Hospital-Onset Clostridioides Difficile Infection Rates Among US Hospitals  
  Pranita D Tamma, Al Roy Ahn, Sara E Cosgrove, JAMA Network Open
• Integrating Bedside Nurses into Antibiotic Stewardship: A Practical Approach  
  Pranita D Tamma, Sara E Cosgrove, Infection Control and Hospital Epidemiology
• How Frequently Are Hospitalized Patients Colonized with Carbapenem-Resistant Enterobacteriaceae (CRE) Already on Contact Precautions for Other Indications?  
  Pranita D Tamma, Sara E Cosgrove, Clare Rock, Lisa L Maragakis, Aaron M Milstone, Infection Control and Hospital Epidemiology
• Determining the optimal carbapenem MIC that distinguishes carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant Enterobacteriaceae  
  Tamma PD, Huang Y, Opene BN, & Simner, PJ, Antimicrob Ag Chemother, 1/1/2016
• A Clinical Decision Tree to Predict Whether a Bacteremic Patient is Infected With an ESBL-Producing Organism  
  Goodman K, Lessler J, Cosgrove SE, Harris AD, Lautenbach E, Han JH, Milstone AM, Masey C, & Tamma PD, Clin Infect Dis Clin Infect Dis, 1/1/2016
• Peripherally Inserted Central Venous Catheter Complications in Children Receiving Outpatient Parenterally Antibiotic Therapy (OPAT)  
  Kovacich A, Tamma PD, Advani S, Popoola VO, Clantuoni E, Gosey L, Milstone AM, Infect Contr Hosp Epidemiol, 1/1/2016
• Trends in Chlorhexidine Use in United States Neonatal Intensive Care Units: Results from a Follow-Up National Survey  
  Johnson J, Bracken R, Tamma PD, Aucott SW, Bearer C, Milstone AM, Infect Contr Hosp Epidemiol, 1/1/2016
• Sustained Impact of an Antibiotic Stewardship Intervention for Community-Acquired Pneumonia  
  Li DX, Ferrada M, Avdic E, Tamma PD, & Cosgrove SE, Infect Contr Hosp Epidemiol, 1/1/2016
• Evaluation of Multiple Methods for the Detection of Gastrointestinal Colonization of Carbapenem-Resistant Organisms from Rectal Swabs  
  Simner PJ, Martin I, Opene B, Tamma PD, Carroll KC, & Milstone AM, J Clin Micro, 1/1/2016
• Addressing the Appropriateness of Outpatient Antibiotic Prescribing in the United States: An Important First Step  
  Tamma PD & Cosgrove SE, JAMA, 1/1/2016
• Cefepime Therapy for Cefepime-Susceptible Extended-Spectrum Beta-Lactamase–Producing Enterobacteriaceae Bacteremia  
  Wang R, Cosgrove SE, Tschudin-Sutter S, Han JH, Turnbull AE, Hsu AJ, Avdic E, Carroll KC, & Tamma PD, Open Forum Infect Dis, 1/1/2016
• Risk Factors for Resistance to Beta-Lactam/Beta-Lactamase Inhibitors and Ertapenem in Bacteroides Species Bacteremia  
  Smith JM, Avdic E, Tamma PD, Zhang L, Carroll KC, Cosgrove SE, Antimicrob Ag Chemo, 1/1/2015
• Low-dose Gentamicin for Uncomplicated Enterococcus faecalis Bacteremia May be Nephrotoxic in Children  
  Ibrahim SL, Zhang L, Brady TM, Hsu AJ, Cosgrove SE, Tamma PD, Clin Infec Dis, 1/1/2015
• Carbapenem Therapy is Associated with Improved Survival Compared to Piperacillin-Tazobactam in Patients with ESBL Bacteremia  
  Tamma PD, Han JH, Rock C, Harris AD, Lautenbach E, Hsu AJ, Avdic E, Cosgrove SE, Clin Infec Dis, 1/1/2015
• The use of a combination antibiograms to assist with the selection of appropriate antimicrobial therapy for carbapenem-resistant Enterobacteriaceae infections  
  Hsu AJ, Carroll KC, Milstone AM, Avdic E, Cosgrove SE, Vilasoa M, Tamma PD, Infect Contr Hosp Epidemiol, 1/1/2015
• Impact of toxigenic Clostridium difficile colonization on the risk of subsequent Clostridium difficile infection in ICU patients  
  Tschudin-Sutter S, Carroll KC, Tamma PD, Sudekum ML, Frei R, Widmer AF, Ellis BC, Bartlett J, Perl TM, Infect Contr Hosp Epidemiol, 1/1/2015
• Antimicrobial Stewardship: A National Priority  
  Larru B, Tamma PD, Pediatr Rev, 1/1/2015
• Predictors of first recurrence of Clostridium difficile infections in children  
  Tschudin-Sutter S, Tamma PD, Milstone AM, Perl TM, Pediat Infect Dis J, 1/1/2014
• The Treatment of Multidrug-Resistant Gram-Negative Infections in Children  
  Hsu AJ, Tamma PD, Clin Infect Dis, 1/1/2014
• Antibiotic Susceptibility of Common Pediatric Uropathogens in the United States  
  Tamma PD, Sklansky DJ, Palazzi DL, Swami S, Milstone AM, Clin Infect Dis, 1/1/2014
• Reply to Nguyen and colleagues  
  Tamma PD, Sklansky DJ, Palazzi DL, Swami S, Milstone AM, Clin Infect Dis, 1/1/2014
• Antimicrobial Stewardship: Another Focus for Patient Safety?  
  Tamma PD, Holmes A, Dodds AE, Curr Op Infect Dis, 1/1/2014
• Optimizing Therapy for Vancomycin-Resistant Enterococcal Bacteremia in Children  
  Tamma PD, Hsu AJ, Curr Op Infect Dis, 1/1/2014
• Challenges in the Management of Infections due to Carbapenem-Resistant Enterobacteriaceae  
  Drekonja DM, Beekmann SE, Elliott S, Mukundan D, Polenakovik H, Rosenthal M, Tamma PD, Polgreen PM, Weissman SJ, Infect Control Hosp Epi, 1/1/2014
• The Prediction of Complicated Clostridium difficile Infections in Children  
  Tschudin-Sutter S, Tamma PD, Milstone AM, Perl TM, Infect Control Hosp Epi, 1/1/2014
• Join now to see all

Books/Book Chapters

• Practical Healthcare Epidemiology 
  Chapter: Detecting and Limiting the Transmission of Multidrug-Resistant Gram-Negative Pathogens. 
  Tamma PD2016
• The Harriet Lane Handbook 
  Chapter: Chapter 17: Microbiology and Infectious Disease 
  Tamma PDLippincott Williams & WilkinsEdition 20th,2014
• Oski’s Pediatric Certification and Recertification Board Review: Infectious Diseases 
  Tamma PDLippincott Williams & Wilkins2011

Lectures

• MDROs in Immunocompromised Children: Rethinking Epidemiology and Empirical Therapies. 
  Baltimore, MD - 1/1/2016
• Stewardship in Clinical Practice: Institutional Activities & Barriers to Success 
  Boston, MA - 1/1/2016
• Utilization of non-carbapenem beta-lactams for directed treatment of ESBL infections. 
  Boston, MA - 1/1/2016
• Antimicrobial Stewardship and Its Impact on Gram-Negative Resistance 
  Cali, Colombia - 1/1/2016
• Evaluating the Impact of Antimicrobial Stewardship Interventions 
  Cali, Colombia - 1/1/2016
• The Diagnosis of Carbapenem-Resistant Enterobacteriaceae 
  Cali, Colombia - 1/1/2016
• The Epidemiology and Treatment of CRE Infections 
  Georgetown University School of Medicine, District of Columbia - 1/1/2016
• Antibiotic Stewardship in Clinical Practice and Barriers to its Success. 
  National Academy of Medicine, Mexico City, Mexico - 1/1/2016
• Double Coverage for Gram-Negative Infections: Why we do not need it. 
  New Orleans, LA - 1/1/2016
• The Use of Non-carbapenem Beta-lactams for the Treatment of ESBL Infections 
  New Orleans, LA - 1/1/2016
• The State of Gram-Negative Resistance in the United States 
  Philadelphia, PA - 1/1/2016
• Discuss the Importance of Appropriately Defining the Exposures and Outcomes Central to Antibiotic Stewardship Research in the Inpatient Setting. 
  San Diego, CA - 1/1/2016
• Establishing Clinical Relevant Antibiotic Breakpoint Interpretive Criteria. 
  Silver Spring, MD - 1/1/2016
• Impact of Antimicrobial Stewardship on Patient Safety. 
  Cali, Colombia - 1/1/2015
• Zero Bacteremia: Myth or Reality? 
  Cali, Colombia - 1/1/2015
• Outpatient Antimicrobial Use. 
  Johns Hopkins Hospital, Baltimore, MD - 1/1/2015
• Evaluating the Effect of Antibiotic Stewardship Interventions: How to Assess the Impact on Patient-Centered Outcomes? 
  San Diego, CA - 1/1/2015
• Recent Publications all Stewards should be Aware of. 
  San Diego, CA - 1/1/2015
• The Treatment of Multidrug-Resistant Gram-Negative Infections in Children. 
  San Diego, CA - 1/1/2015
• Clostridium difficile Infection Prevention in Hospitalized Children. 
  San Diego, CA - 1/1/2015
• The Use of Combination Antibiotic Therapy for the Treatment of Gram-Negative Infections. 
  St. Jude’s Children’s Research Hospital, Memphis, TN - 1/1/2015
• The Diagnosis and Treatment of Carbapenem-Resistant Enterobacteriaceae. 
  University of Wisconsin at Madison, Madison, WI - 1/1/2015
• Emerging Antimicrobial Resistance in Pediatric Patients. 
  Washington University School of Medicine, St. Louis, MO - 1/1/2015
• Giving the Proper Dose: How The Clinical and Laboratory Standards Institute can Help. 
  Diego, CA - 1/1/2014
• Preventing Clostridium difficile Infection in the Intensive Care Unit. 
  Greensboro, NC - 1/1/2014
• Join now to see all